Ainsley Health

Featuring: Michele Wispelwey

Hosted by: James Chhetree

This episode of Ainsley Health features Michele Wispelwey, Co-Founder of FemGevity. Hosted by James Chhetree, the conversation explores why perimenopause and menopause care is so often missed, how FemGevity moved from a direct-to-consumer subscription to a model embedded inside physician practices, and what is changing for women's health policy on Capitol Hill.

Michele's path to FemGevity is both personal and professional. She lost her mother at 51 after menopause symptoms were misdiagnosed, and she watched her family move through a siloed system built around sick care. She once planned a career in fashion marketing and briefly attended Parsons School of Design before spending about 20 years in the diagnostic lab industry, working alongside physicians on specialty testing for women's health. FemGevity went live in 2023 as a direct-to-consumer subscription. In 2025 she wound that business down and relaunched it as a B2B collaborative care model that works inside the physician group.

The conversation explores several key themes:

Menopause Is One Day: Why menopause is technically the single day that marks 12 months without a period, why perimenopause can last 7 to 14 years before it, and why Michele says treating symptoms as something to get through misses what they signal about long-term health.

Starting at 35: Why FemGevity begins working with women at 35, and how baseline labs and ongoing monitoring can make the transition less symptomatic.

The Training Gap: Why Michele says fewer than 6% of physicians are adequately trained in menopause care, and why she blames medical education and insurance-driven visit volume, not doctors.

From D2C to B2B: What the direct-to-consumer launch proved, why patients paying out of pocket kept moving between FemGevity and their own doctors, and why the company relaunched to work under the physician's oversight.

Protocols Physicians Can Trust: How FemGevity rebuilt its clinical foundation with more than 150 proprietary protocols, a 200-question proprietary intake, a view across 14 clinical systems, and strict referral rules so the model extends a practice instead of competing with it.

Selling to Physicians: The pushback Michele hears, from "don't tell me how to practice medicine" to skepticism about projected revenue, and the metrics practices care about: physician satisfaction, patient satisfaction, and reimbursement.

Gut Health First: Why FemGevity often tests and treats the gut before starting a hormone regimen, and why Michele calls the gut the command center of overall health.

Policy and Capitol Hill: What Michele saw at menopause and perimenopause advocacy day in Washington, including bipartisan bills focused on education, training, and research data, the lack of a diagnosis code for perimenopause, and the discussion of FDA approval for testosterone for women.

Insurance and Reimbursement: What insurance covers and what it does not, including compounded hormones, and why Michele sees reimbursement policy as the most important lever for making this care accessible.

Menopause at Work: Why some women leave the workforce during this transition, and why Michele believes workplace support deserves far more attention.

Founder Lessons: Raising capital, restructuring the company with a board and a chief medical officer, learning to sell to physicians instead of patients, and why quitting has never been an option.

For founders, physicians, practice leaders, healthcare operators, and anyone who wants to understand where women's midlife care is heading, this episode offers a grounded look at a model built to work inside the system physicians and patients already use.

Please note that the content here is for informational purposes only; it should not be taken as medical, legal, business, tax, or investment advice or be used to evaluate any investment or security, and is not directed at any investors.

Featuring: Zain Qayyum

Hosted by: James Chhetree

This episode of Ainsley Health features Zain Qayyum, CEO of MedSender. Hosted by James Chhetree, the conversation explores why healthcare still runs on fax, how referrals get lost in administrative backlogs, and how AI can automate the front-office work that delays patient care.

Zain's path into health tech started on a pre-med track. Driving hours between health systems to collect paper records for his mother, and watching his grandfather wait weeks for specialist appointments, convinced him the bigger problem was healthcare operations. MedSender, founded in 2017 before the current AI wave, began as an attempt to eliminate faxing entirely, and evolved into a platform that automates the workflows around it: processing referrals, creating and updating charts, verifying insurance, and reaching out to patients within seconds instead of weeks.

The conversation explores several key themes:

Why Healthcare Still Runs on Fax: How compliance concerns from the early days of email entrenched fax into healthcare's core infrastructure, and why replacing it is like rewiring the electrical grid.

The Referral Black Hole: What happens between the moment a referral arrives and the moment someone acts on it — often two to four weeks later — and what that delay costs patients and practices.

Real Results: How Anne Arundel Dermatology raised a regional referral conversion rate from 20% to 62% after implementing MedSender, uncovering demand they assumed didn't exist, and how the platform now processes referrals in an average of 32 seconds.

The Data Blind Spot: Why most practices tolerate referral leakage for so long — many track referrals in a spreadsheet at best, and don't know their conversion rate until a system measures it.

Building Before the AI Hype: Why years of ironing out edge cases, and building tools for the work AI can't do — signatures, document editing, splitting and merging — matter more than a polished demo.

AI and Staffing: Why Zain sees AI as a way to scale a practice without scaling payroll — preventing burnout for existing staff rather than replacing them — and why "AI won't replace people, but people who use AI will."

Myra, the AI Voice Agent: How MedSender's voice agent calls patients with benign lab results, nudges unscheduled referrals, and catches missed follow-ups before patients fall through the cracks.

Where Healthcare AI Overpromises: Why any vendor claiming 100% automation with zero human involvement should raise flags, and why healthcare's zero margin for error demands a human in the loop for edge cases.

Hard Lessons for Founders: Why the biggest barriers in healthcare are often business hurdles rather than technical ones — including EHR vendors that won't provide API access — and why tech founders consistently overestimate how modern healthcare's infrastructure really is.

For founders, practice leaders, healthcare operators, and anyone interested in where AI can remove real administrative burden, this episode offers a grounded look at the systems that decide how quickly patients get care.

Please note that the content here is for informational purposes only; it should not be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security, and is not directed at any investors.

Featuring: Dennis Cardoza

Hosted by: James Chhetree

In the first video episode of the Ainsley Health Podcast, James Chhetree sits down with Dennis Cardoza, Principal at Ainsley Health and former U.S. Congressman from California. The conversation traces a life spent at the intersection of healthcare, policy, and public service — and what that perspective means for the founders, operators, and health systems building the future of care.

Dennis brings a rare vantage point to healthcare's hardest problems: he has lived them as a patient, fought for them as a legislator, and now advises on them as a consultant. He opens up about the childhood kidney condition that nearly took his life, the uninsured surgery that put his family in debt, and the moment at age eight when healthcare and public service became his life's calling. From there, the conversation follows his path through local politics, the building of UC Merced, and his role helping negotiate the final votes for the Affordable Care Act.

Rather than treating policy and technology as separate worlds, Dennis explains why the future of healthcare depends on bringing them together — and why the best innovations fail when they ignore trust, workflow, and affordability.

The conversation explores several key themes:

The Power of Trust in Healthcare: Why trust is the connective tissue between VCs and founders, health systems and consultants, and doctors and patients — and why building it early changes everything.

Engaging Government Before You Need It: Dennis's biggest piece of advice for founders: build relationships with policymakers while you're still building your solution, not when you're already behind on funding codes, certifications, and approvals.

Rural Healthcare in Crisis: A grounded look at the challenges facing rural hospitals — no-show rates, transportation barriers, Medicaid cuts, and the uncompensated care that puts entire institutions at risk.

AI as a Tool, Not a Replacement: Why AI's highest value in medicine is augmenting human judgment, illustrated through the "bio button" that can detect a patient decline 12–14 hours before symptoms appear — and the risks of leaning on AI to replace clinical decision-making.

Why Great Technology Sits on the Shelf: How Ainsley Health helps companies integrate innovation into real clinical workflows, because technology that disrupts the way doctors and nurses work rarely gets adopted.

The Economics of Innovation: Why founders must account for affordability and adoption — not just invention — if their solution is going to reach the patients who need it.

Leadership, Mentorship, and Ethics: Dennis reflects on a career of mentoring future leaders, the lessons that shaped him, and his enduring belief in doing the right thing even when no one is looking.

Dennis also shares stories from building UC Merced against long odds, navigating COVID-era telehealth alongside his physician wife, and the perseverance it takes to turn a difficult mission into reality.

For founders, operators, health system leaders, healthcare executives, and anyone interested in where policy, technology, and patient care intersect, this episode offers a deeply human and experienced perspective on making healthcare work better.

Please note that the content here is for informational purposes only; it should not be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security, and is not directed at any investors.

Featuring: Anirudh Perubotla
Hosted by: James Chhetree

This episode of Ainsley Health features Anirudh Perubotla, Co-Founder and CTO of Floe Health. Hosted by James Chhetree, the conversation explores how healthcare AI can improve care coordination, referral workflows, discharge planning, prior authorization, and the operational systems that shape the patient experience.

Ani brings a builder’s perspective to one of healthcare’s most overlooked challenges: the transitions between care settings. For case managers, discharge planners, nurses, patients, families, payers, and post-acute facilities, the process of moving a patient from the hospital to the right next setting often depends on manual follow-ups, fragmented communication, institutional knowledge, and workflows that were never designed for today’s level of complexity.

Together, James and Ani discuss what it takes to build AI that works inside real healthcare environments. Rather than framing AI as a replacement for human judgment, Ani explains why its highest-value role is often removing repetitive coordination work, surfacing stalled processes, and helping teams act faster without forcing them into yet another system.

The conversation explores several key themes:

Healthcare AI Built for Relief: Why the best products in healthcare are not always the most elegant demos, but the tools that help overwhelmed teams get through the day.

Care Coordination and Case Management: How discharge planning, post-acute placement, referrals, prior authorization, family communication, and transportation can all become points of friction that delay care.

Tribal Knowledge in Healthcare Operations: Why so much of the system still depends on the memory, relationships, and workarounds of experienced case managers, and what happens when that knowledge is not captured.

AI and Human Judgment: Why AI should support care teams by automating manual follow-up and coordination tasks while preserving the human judgment, empathy, and communication patients need.

Building Trust in Healthcare AI: How early-stage companies can start with low-risk, high-value workflows, prove impact, and gradually expand into more complex operational layers.

The Future of Prior Authorization: Ani shares why he believes today’s manual prior authorization process may become one of the administrative workflows that feels outdated in the coming years.

Quiet Operational Intelligence: A look at what healthcare AI could become by 2030, where patients may not know the tools behind the scenes, but they feel the difference through faster scheduling, smoother referrals, clearer communication, and better transitions of care.

Ani also shares his perspective on what makes a strong healthcare AI engineer, why founders should spend time observing real workflows before building, and how industries like automotive manufacturing can offer lessons for operational efficiency in healthcare.

For founders, operators, health system leaders, healthcare executives, and anyone interested in where AI can create practical impact, this episode offers a grounded look at the future of care coordination and the operational infrastructure needed to make healthcare work better for patients and teams.

Please note that the content here is for informational purposes only; it should not be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security, and is not directed at any investors.

Featuring: Seema Alexander
Hosted by: James Chhetree

This episode of Ainsley Health features Seema Alexander, CEO of Disruptive AI, AI business futurist, keynote speaker, and host of The AI CEO Podcast. Hosted by James Chhetree, the conversation explores what it really takes for leaders, founders, and healthcare organizations to move beyond AI curiosity and into practical AI adoption.

Seema brings a business-first lens to the AI conversation, helping executives understand that AI is not just another software tool. It is a fundamental shift in how organizations operate, compete, and create value. The discussion breaks down why the next era of AI will be defined less by hype and more by fluency, workflow redesign, and leadership readiness.

Together, James and Seema explore several key themes:

AI Fluency vs. AI Awareness: Why knowing what the tools do is no longer enough, and why leaders need to understand AI well enough to rethink how their organizations actually work.

Rewiring the Business: How companies can move from scattered experiments to real operational transformation by redesigning workflows around AI, agents, and automation.

The CEO’s Role in AI Adoption: Why AI strategy cannot live only with the technical team, and why executive alignment, governance, and change management are critical to adoption.

Healthcare’s Next Transformation: How AI may reshape healthcare operations, patient engagement, administrative workflows, and the way organizations think about scale.

Human-Centered AI: Why the best AI implementations should make teams more effective, not replace the judgment, trust, and relationships that matter most.

Seema also shares her perspective on the broader AI business landscape, including why many organizations are still in the education phase, what separates serious adopters from passive observers, and how leaders can prepare their teams for the next wave of AI-enabled work.

For founders, operators, healthcare executives, and anyone trying to understand where AI is actually going, this episode offers a practical look at how to lead through the shift from AI as a buzzword to AI as a business operating system.

Please note that the content here is for informational purposes only; it should not be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security, and is not directed at any investors

Featuring: Demetri GiannikopoulosHosted by: Jay Gopal & James Chhetree

This episode of Ainsley Health dives into the evolution of radiology as the vanguard of medical technology with Demetri Giannikopoulos, Chief Innovation Officer at Rad AI. Hosted by James Chhetree, the conversation explores how radiology moved from physical X-ray film to digital imaging decades before the rest of healthcare, and how that early adoption has paved the way for the modern generative AI era.

Demetri brings over 20 years of experience, witnessing the transition from telephone-based dictation to the sophisticated AI synthesis used today. With Rad AI now utilized by 40% of US health systems and 9 out of 10 of the largest radiology practices, Demetri explains why the current shift is less about the technology itself and more about solving the "staccato" workflows that have burdened clinicians for years.

As an industry expert who recently testified before the U.S. Senate on the "Less Hype, More Help" initiative, Demetri provides a comprehensive look at the ethical and practical deployment of AI:

• Clinical Integration over Technology: Why moving from the pilot phase to full-scale implementation requires viewing AI as a governance consideration rather than just a software installation.

• The Family Test: How reducing cognitive load through automated impression synthesis allows radiologists to return home less anxious, effectively "humanizing" the tech-heavy diagnostic process.

• The Digital Front Door: The business and clinical case for Rad AI Continuity, which ensures incidental findings (incidentalomas) in the ER don't fall through the cracks, enabling a "stage shift" to catch diseases like lung cancer earlier.

• The Future of the "Doctor's Doctor": A prediction on how AI will automate nearly 50% of routine tasks, allowing radiologists to move out of isolated workstations and back into the center of the diagnostic conversation.

Demetri also shares personal insights into his own journey navigating the healthcare system as a patient, reinforcing the need for AI to remove the administrative friction of insurance and prior authorizations. For founders, he offers a masterclass in "change management," emphasizing the importance of baselining data and shadowing clinicians to ensure technology adapts to the human, not the other way around.

Please note that the content here is for informational purposes only: should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security: and is not directed at any investors.

Featuring: Zach RosenHosted by: James Chhetree

This episode of Ainsley Health explores the critical intersection of clinical accuracy and patient safety with Zach Rosen, Co-Founder and CEO of Brellium. Hosted by James Chhetree, the conversation dives into how AI can serve as a definitive safety net for ambulatory care, ensuring that the "source of truth" in a medical chart remains both clinically valid and payer-compliant.

Zach’s journey into health tech is deeply personal. After a core medical misdiagnosis led to years of health challenges for him and his family, he founded Brellium with a singular mission: to ensure that what happened to him never happens to another patient. By auditing millions of visits across all 50 states, Brellium aligns provider incentives with patient outcomes, moving beyond standard software into a realm where near-perfect accuracy is a requirement, not an option.

As a second-time founder navigating the high-stakes world of medical regulation, Zach provides a masterclass on building trust in a noisy AI market:

• The Regulatory Intelligence Network: How Brellium crowdsources "edge case" requirements from over 100 payers to provide real-time intelligence for independent and mom-and-pop practices.

• The Golden Thread: Why the cohesion of the patient narrative—from initial visit to hospice care—is the ultimate defense against both federal oversight and adverse clinical outcomes.

• Accuracy vs. Empathy: Zach’s counterintuitive stance that while accuracy is the bedrock of AI, empathy is the necessary bridge that ensures a patient actually internalizes and acts on clinical data.

Brellium rejects the idea of "AI for the sake of AI." Instead, Zach emphasizes a customer-first philosophy where technology is merely the implementation detail for solving massive operational inefficiencies. He discusses:

• Clawback Protection: The logic behind Brellium’s bold claim to foot the bill if a payer pulls back reimbursement on an approved chart—a move that perfectly aligns their success with their customers' risk mitigation.

• The Ambulatory Focus: Why Brellium prioritizes the "mom-and-pop" businesses and few-site locations that render the vast majority of care in America but often lack access to enterprise-grade technology.

• The Future of the Chart: Why humans will stop manually auditing PDFs, but the medical chart will remain the indispensable, verifiable source of truth for the patient journey.

The episode concludes with Zach’s advice for technical founders: talk to a statistically significant number of people early on to compound your learnings. His most surprising insight? That early on, even the most serious documentation could be derailed by something as simple as a provider recording a therapy session spent playing Xbox—proving that without a safety net, even the most fundamental gaps can go unnoticed.

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors.

Featuring: Cole Johnson

Hosted by: Jay Gopal and James Chhetree

This episode of Ainsley Health explores the future of social intelligence and the broken feedback loop between consumers and corporations with Cole Johnson, Founder of Echo. Hosted by Jay Gopal and James Chhetree, the conversation delves into how language models have unlocked an entirely new category of human understanding—one that treats every voice equally rather than amplifying the loudest.

Cole's journey is a study in compounding curiosity. From founding La Tree (now Terra Nova) at Georgia Tech to prosthetics research and a Caltech fellowship, Cole discovered "shared autonomy"—the bidirectional negotiation between a human and an intelligent system. That insight became the intellectual foundation for Echo: language models could finally enable qualitative back-and-forth at a scale previously reserved only for quantitative systems.

As a researcher-turned-founder at the intersection of AI and human behavior, Cole provides a rare perspective on why every existing method of understanding public intent is fundamentally flawed:

The Broken Trifecta: Social listening captures only the loudest voices. Polling has a 0.1% completion rate. Focus groups max out at 50 people for massive cost. None can do qualitative analysis at quantitative scale.

The Demographics Misconception: Demographics and psychographics were always just heuristics for intent—proxies mistaken for the real thing. Echo asks the right questions, to the right people, at the right time, achieving a nearly 90% completion rate.

The Bot Problem: With 12 to 80 percent of voices on X potentially bots, Echo's platform fundamentally lacks the incentive structure that rewards bot behavior—no engagement to game, no audience to influence.

Echo rejects the prevailing agentic AI philosophy of replacement. Rather than automating departments, Echo positions itself as a democratic listening device that routes genuine human feedback to the organizations that need it most. Cole discusses:

Privacy by Architecture: Why separating the monetization vehicle from the communication medium is foundational for safe AI—drawing a direct line from advertising's degradation to the current danger of monetization bleeding into chat-based AI.

Crisis Narrative Validation: How Echo's systems detect emerging narratives every five to ten minutes, then validate whether loud online voices actually represent majority sentiment through real user feedback.

The Anti-Replacement Thesis: Instead of intermediating humans, Echo extracts, interprets, and routes insights to corporations that genuinely cannot hear what their consumers are saying.

The episode concludes with Cole's five-year moonshot: a decentralized, white-label intelligence layer where bidirectional communication between organizations and individuals is routed at scale. His counterintuitive advice? In industry, try many things rapidly and backfill the foundation as weight accumulates. And his most surprising discovery? People use AI chatbots not as utilitarian tools, but as companions—replacing search engines with something far more conversational and revealing.

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors

Description

Featuring: Martin Arum

Hosted by: Jay Gopal and James Chhetree

This episode of Ainsley Health explores the "Fountain of Youth" and the shifting healthcare business model with Martin Arum, Founder and CEO of FR Global Health. Hosted by Jay Gopal and James Chhetree, the conversation delves into how decentralized regulatory environments and cutting-edge biotech are converging to push the boundaries of human healthspan.

Martin’s journey is a masterclass in professional evolution, transitioning from corporate law and defense technology into the high-stakes world of biotech and longevity. After building and selling a legal tech firm to a major government contractor, Martin redirected his focus toward healthcare, specifically cellular and neuro therapies. Today, he sits at the intersection of investment and innovation, identifying the "personality equation" that allows founders to survive the grueling emotional toll of the startup world.

As a visionary in the longevity space, Martin provides a unique perspective on the "regulatory relief valve" found in cross-border medical hubs and how they are accelerating the path to a 150-year lifespan:

• The Mexico Epiphany: Martin discusses the radical efficiency of the San Diego-Tijuana border, where "inaccessible" experimental therapies in the U.S. become immediate commercial realities. He explains how this "back door" to American healthcare is a multi-billion dollar industry driven by cost, access, and innovation.

• The Investment Gap: With only 10% of FDA-track drugs reaching success, Martin highlights why traditional Venture Capital often retreats from early-stage biotech. He explores how family offices and foundations are stepping in to fund rare disease research and bridge the "binary risk" of long-term drug development.

• Biological Rejuvenation: From 3D-printed body parts utilizing a patient’s own stem cells to AI-driven drug discovery, Martin outlines the shift from treating sickness to optimizing "healthspan"—ensuring our "active" years match our chronological longevity.

FR Global Health is redefining the biotech roadmap by embracing a "dual-path" commercial model. By establishing R&D and clinical operations in more permissive regulatory environments like Mexico, they are able to iterate faster and provide life-changing therapies to patients today rather than a decade from now. Martin discusses:

• AI as a Mega-Catalyst: Why the "AI Tsunami" is the ultimate accelerator for personalized medicine, diagnostics, and the design of complex medical devices.

• Medical Tourism as a Systemic Shift: Moving beyond "cheap dental work" to specialized regenerative hubs that offer sophisticated neuromodulation and fertility treatments.

• The Consolidation Curve: Why the current fragmentation of the longevity market will eventually give way to systemic, whole-body treatment models as the technology matures over the next 10 to 20 years.

The episode concludes with a challenge to founders: the importance of self-discovery. Martin emphasizes that while technology like AI is a prerequisite for success, the "fabric" of the founder—their resilience and conviction—is the only thing that survives the "long haul" of biotech innovation. His bold advice? Pause and reflect on your own "personality equation" before trying to change the world’s biology.

_______________________________________________________________

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any Ainsley Capital fund. Ainsley Capital and its affiliates may maintain investments in the companies discussed.

Featuring: Cullen Murray-Kemp

Hosted by: Jay Gopal and James Chhetree

This episode of Ainsley Health explores the power of local health literacy and the vital role of independent medicine with Cullen Murray-Kemp, CEO of HealthLinks. Hosted by Jay Gopal and James Chhetree, the conversation delves into how authentic storytelling and clinician-led decision-making are essential for rebuilding trust in an increasingly fragmented healthcare landscape.

Cullen’s journey is rooted in a passion for journalism and a realization that local communities were living in "healthcare information deserts." Starting with a small health section in a lifestyle magazine, Cullen built HealthLinks into a multi-channel publishing and marketing powerhouse that reaches hundreds of thousands of readers. His approach is defined by "humanness"—the belief that patients should never feel like a number and that doctors should be seen as partners, not just providers. During the pandemic, he pivoted the business to digital and podcasting, doubling down on the mission that quality health information should be a right, not a privilege.

As a bridge between journalism and marketing, Cullen provides a unique perspective on the "reactive" nature of U.S. healthcare and how to shift the paradigm toward proactivity:

The Trust Gap: Cullen discusses the rise of "Dr. Google" and "Dr. ChatGPT," explaining why personalized, local storytelling is the only way to re-establish the sacred patient-provider bond.

The Independence Crisis: With only 14% of physicians in South Carolina remaining independent, Cullen highlights the dangers of corporate "StairMaster" healthcare, where clinicians are often discouraged from making decisions outside of centralized systems.

The Power of the Collective: He advocates for "water cooler time"—independent physician networks that share best practices in AI, revenue cycle management, and staffing to compete with massive hospital systems.

HealthLinks is redefining healthcare communication by maintaining a strict ethical line between editorial integrity and marketing. By ensuring every piece of content is fact-checked by MDs, Cullen ensures that literacy remains the primary goal. He discusses:

AI as a Co-pilot: Why independent practices must adopt ambient listening and AI scribes to combat burnout, while ensuring care remains human-led.

Clinically-Led Marketing: Moving away from "generic" corporate broadcasts to real-time, narrative-driven content that features actual patients and clinical outcomes.

Breaking the Silos: How collaboration between independent providers can create a "metaphorical physician room" where innovation outpaces bureaucratic inertia.

The episode concludes with a call to action for the "quarterbacks" of healthcare: the primary care providers. Cullen envisions a future where healthcare is "broken down and reimagined" to put the patient and provider back in the center of the room. His bold advice for 2026? Don't just work harder, work smarter by leveraging the "collaborative firepower" of your local medical community.

____________________________________________________________________

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any Ainsley Capital fund. Ainsley Capital and its affiliates may maintain investments in the companies discussed.